Survival benefit needed to undergo chemotherapy: Patient and physician preferences.

Ines Vaz LuisAnne O'NeillKaren SepuchaKathy D MillerEmily BakerChau T DangDonald W NorthfeltEric P WinerGeorge W SledgeBryan SchneiderAnn H Partridge

Published in: Cancer (2017)

Among patients who received contemporary adjuvant chemotherapy in a randomized controlled trial, we found substantial variation in preferences regarding benefits that justified undergoing chemotherapy. Differences between patients' and physicians' choices were also apparent. Eliciting preferences regarding risks and benefits of adjuvant chemotherapy is critical. Cancer 2017;123:2821-28. © 2017 American Cancer Society.

Keyphrases

papillary thyroid
end stage renal disease
primary care
squamous cell
chronic kidney disease
ejection fraction
locally advanced
emergency department
decision making
peritoneal dialysis
squamous cell carcinoma
lymph node metastasis
case report
childhood cancer
magnetic resonance
climate change